Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Progenics Pharmaceuticals buy Quitte

Start price
€5.40
18.09.18 / 50%
Target price
€7.22
18.03.19
Performance (%)
-24.21%
End price
€4.10
18.03.19
Summary
This prediction ended on 18.03.19 with a price of €4.10. The prediction for Progenics Pharmaceuticals disappointed with a performance of -24.21%. Quitte has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Progenics Pharmaceuticals - - - -
iShares Core DAX® -0.621% 1.080% 11.291% 16.439%
iShares Nasdaq 100 -4.503% -5.432% 22.172% 39.304%
iShares Nikkei 225® -2.562% -1.617% 7.262% 8.383%
iShares S&P 500 -1.706% -1.223% 22.550% 40.997%

Comments by Quitte for this prediction

In the thread Progenics Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) -24.21%
Target price 7.216
Change
Ends at 18.03.19

Azedra kommt

https://seekingalpha.com/news/3390597-progenics-adds-azedra-nccn-guidelines-pheochromocytoma-paraganglioma

Prediction Buy
Perf. (%) -24.21%
Target price 7.216
Change
Ends at 18.03.19

(Laufzeit überschritten)

Stopped prediction by Quitte for Progenics Pharmaceuticals

buy
Progenics Pharmaceuticals

Start price
Target price
Perf. (%)
€4.05
22.08.19
€5.00
29.06.20
-8.07%
29.06.20

buy
Progenics Pharmaceuticals

Start price
Target price
Perf. (%)
€7.50
16.03.18
€9.47
17.09.18
-32.51%
17.09.18

buy
Progenics Pharmaceuticals

Start price
Target price
Perf. (%)
€3.85
30.01.14
€4.30
25.03.14
-20.86%
25.03.14